Cite
Lorente L, Rodriguez ST, Sanz P, et al. Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality. Oncotarget. 2018;9(30):21552-21559doi: 10.18632/oncotarget.25097.
Lorente, L., Rodriguez, S. T., Sanz, P., Pérez-Cejas, A., Padilla, J., Díaz, D., González, A., Martín, M. M., Jiménez, A., Cerro, P., & Barrera, M. A. (2018). Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality. Oncotarget, 9(30), 21552-21559. https://doi.org/10.18632/oncotarget.25097
Lorente, Leonardo, et al. "Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality." Oncotarget vol. 9,30 (2018): 21552-21559. doi: https://doi.org/10.18632/oncotarget.25097
Lorente L, Rodriguez ST, Sanz P, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Barrera MA. Patients with high serum substance P levels previously to liver transplantation for hepatocellular carcinoma have higher risk of one-year liver transplantation mortality. Oncotarget. 2018 Apr 20;9(30):21552-21559. doi: 10.18632/oncotarget.25097. eCollection 2018 Apr 20. PMID: 29765559; PMCID: PMC5940410.
Copy
Download .nbib